Agelli v. Burwell

164 F. Supp. 3d 69, 2016 U.S. Dist. LEXIS 20022, 2016 WL 695985
CourtDistrict Court, District of Columbia
DecidedFebruary 19, 2016
DocketCivil Action No. 2014-1720
StatusPublished
Cited by1 cases

This text of 164 F. Supp. 3d 69 (Agelli v. Burwell) is published on Counsel Stack Legal Research, covering District Court, District of Columbia primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Agelli v. Burwell, 164 F. Supp. 3d 69, 2016 U.S. Dist. LEXIS 20022, 2016 WL 695985 (D.D.C. 2016).

Opinion

MEMORANDUM OPINION

Amit P. Mehta, United States District Judge

I. INTRODUCTION

In November 2003, Plaintiff Maria Agel-li entered into a confidential Memorandum *71 of Understanding (MOU) with her employer, the National Institute of Health (NIH), to resolve an equal employment opportunity (EEO) complaint that she had filed. As part of the MOU, NIH agreed that it would expunge from her personnel records an unflattering performance review from 2003, which had prompted the EEO complaint. Fast forward nine years to October 2012. Plaintiff learned for this first time that NIH had not in fact destroyed the negative performance review as required by the MOU. Instead, NIH had preserved and circulated it among staff members. Believing that NIH’s actions violated not only the MOU, but also the Privacy Act, Plaintiff filed this suit in October 2014.

The primary question this case presents is whether Plaintiff timely filed her suit under the Privacy Act. The Act provides a two-year limitations period that commences when the plaintiff knows or should have known of the alleged violation. Here, the court concludes that Plaintiff knew or should have known about NIH’s failure to destroy the 2003 negative performance review more than two years before she filed suit. Accordingly, the court grants Defendant’s Motion for Summary Judgment and enters judgment in favor of Defendant.

II. BACKGROUND

A. Factual Background

1. Plaintiffs 2003 EEO Complaint

Plaintiff Maria Agelli is a physician epidemiologist, employed as a Medical Officer at NIH’s National Cancer Institute (“Cancer Institute”). Compl., ECF No. 1, ¶ 15; Aff. of Dr. Maria Agelli, ECF No. 12-2 [hereinafter Agelli Aff.], ¶ 3. Plaintiff began working at NIH in 2001 as an employee of the Cancer Institute’s Cancer Training Branch. Agelli Aff. ¶ 4. In 2002, Dr. Carolyn Strete became Plaintiffs supervisor. Id. ¶¶ 12-14. Conflicts quickly arose between Plaintiff and Dr. Strete. Id. ¶¶ 13-16.

The following year, in September 2003, Dr. Strete drafted a highly critical performance evaluation of Plaintiff in which Dr. Strete recommended that Plaintiff be transferred to another component of NIH (the “2003 Performance Review”). Id. ¶ 18; Def.’s Mot. to Dismiss or, in the Alter., for Summ. J. [hereinafter Def.’s Mot.], Ex. 1, ECF No. 7-2 [hereinafter MOU]. In response, Plaintiff filed an EEO complaint alleging that the 2003 Performance Review was the product of discrimination based on her sex and national origin. Agelli Aff. ¶ 22.

In November 2003, Plaintiff and NIH resolved her discrimination complaint by entering into a confidential Memorandum of Understanding (MOU). Id. ¶ 33. As part of the MOU, NIH agreed to assign Plaintiff to another component of NIH for one year. Def.’s Mot., Ex. 1 at 1. It also agreed that the Cancer Institute “will use the interim 2003 performance evaluation mutually agreed upon in the latest revision.” Id. And, most importantly for present purposes, NIH agreed that the Cancer Institute would not “retain any written record of negative comments in any personnel folder.” Id. In other words, NIH agreed to remove the 2003 Performance Review from Plaintiffs personnel file.

2. NIH’s Treatment of the 2003 Performance Review

Move the calendar forward almost nine years to the fall of 2012. Plaintiff had filed a new EEO complaint, which was pending before the Equal Employment Opportunity Commission. Def.’s Mot., Ex. 3. On October 2, 2012, Plaintiff received documents from NIH relating to her new EEO complaint. Agelli Aff. ¶¶ 42, 45. Among those records was an email dated January 2005 from Dr. Strete to Dr. Ernie Hawk, who *72 was “the newly appointed Officer Director” of the Cancer Institute (“Strete Email”). Id. ¶ 85. According to Plaintiff, the Strete Email was among thousands of pages NIH produced on October 2, 2012. Id. ¶¶ 42, 45.

The Strete Email evidenced a clear violation of the MOU. Attached to the Email was Plaintiffs 2003 Performance Review, which NIH was supposed to have destroyed under the terms of the MOU. Def.’s Mot., Ex. 1. Moreover, the Email showed Dr. Strete sharing the 2008 Performance Evaluation with another NIH colleague, Dr. Hawk. In the text of the email, Dr. Strete wrote that her “comments [in the 2003 Performance Review] were significantly watered down by [another NIH official] and those went to [Plaintiffs] official files. Therefore, I assume these” — meaning the 2003 Performance Review comments — “are dead. I am only sending these to you so that you can see her through my eyes. Obviously this is confidential.” Id. at 1.

The precise date on which Plaintiff actually saw the Strete Email, and learned of NIH’s violation of the MOU, is in dispute. Following her discovery of the Strete Email, Plaintiff wrote two letters to Debra Chew, the Director of NIH’s EEO office. In the first letter, dated October 11, 2012 (“October 11th Letter”), referring to her discovery of the Strete Email, Plaintiff wrote:

On October 2, 2012, while examining documents produced by the agency in response to my discovery requests ... the six pages of defamatory lies authored by Dr. Strete — that should have been destroyed in 2003 — and one defamatory memo (so far), which also was to be destroyed in 2003, were instead perfectly preserved. Not only that, but the agency records show that these defamatory documents have been freely shared among NCI management.

Def.’s Mot., Ex. 3, ECF No. 7-4 (emphasis added).

On January 3, 2013, Plaintiff again wrote to Chew (the “January 3rd Letter”), apparently because Chew had not responded to the October 11th Letter. Def.’s Reply, Ex. 6, ECF No. 13-1. In the January 3rd Letter, Plaintiff reiterated that she had discovered the Strete Email on October 2, 2012. In the first line of that letter, she wrote: “With my October 11, 2012 letter, I informed you that on October 2, 2012, I learned that NCI management has affirmatively failed to comply with the agreement they had reached with me through a [MOU] on November 2003.” Id. (emphasis added).

Notwithstanding the fact that the October 11th and January 3rd Letters both clearly state that Plaintiff learned about the Strete Email on October 2, 2012, Plaintiff now claims otherwise. In a sworn affidavit, Plaintiff attests that she received— but did not review — the documents from NIH on' October 2, 2012. Agelli Aff. ¶ 41. She did not actually review, and therefore discover, the Strete Email, Plaintiff attests, until October 11, 2012 — the day she wrote Chew. Id. ¶¶ 46, 50 (“I saw the document in question on October 11, 2012, for the first time. ... It was at about 2 AM on October 11, 2012, when I found [the Strete Email] among hundreds of unrelated document pages.”).

B. Procedural History

Plaintiff filed her Complaint pro se

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Page v. Comey
District of Columbia, 2022

Cite This Page — Counsel Stack

Bluebook (online)
164 F. Supp. 3d 69, 2016 U.S. Dist. LEXIS 20022, 2016 WL 695985, Counsel Stack Legal Research, https://law.counselstack.com/opinion/agelli-v-burwell-dcd-2016.